PolyPid Ltd.
PYPD | NASDAQ
$5.37
+$0.20 (+3.87%)
Sep 22, 2026, 2:45 PM ET · Market open
Company Profile
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Key Executives
| Name | Position |
|---|---|
| Dalit Hazan | Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs |
| Dikla Czaczkes Akselbrad | Chief Executive Officer & Director |
| Jonny Missulawin | Chief Financial Officer |
| Ori Warshavsky | Chief Operating Officer - US |
| Jean-Marc Hagai | Chief Commercial Officer |
| Maria Rubin | Executive Vice President of Operations |
| Nurit Tweezer-Zaks | Chief Medical Officer |
| Rivi Lev-ari | Vice President of Human Resource |
| Tal Vilnai | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | 6-K | Filing |
| Aug 12, 2026 | S-8 | Filing |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | 6-K | Filing |
| Jul 29, 2026 | 6-K | Filing |
| Jul 21, 2026 | 6-K | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
PolyPid Ltd.
| Country | Israel |
| IPO Date | Jun 25, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 72 |
| CEO | Dikla Czaczkes Akselbrad |
Contact Details
18 Hasivim Street Petah Tikva,
HM 4959376 Israel
Stock Details
| Ticker Symbol | PYPD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001611842 |
| CUSIP Number | M8001Q118 |
| ISIN Number | IL0011326795 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove PYPD